GABAPENTIN
NDC 72737-005, GABAPENTIN, capsule, from STALLION LABORATORIES PRIVATE LIMITED.
- Product NDC
- 72737-005
- Status
- Listed
- Labeler
- STALLION LABORATORIES PRIVATE LIMITED
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219319
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72737-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN100 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72737-005-01 | 72737000501 | 30 CAPSULE in 1 BOTTLE (72737-005-01) |
| 72737-005-02 | 72737000502 | 100 CAPSULE in 1 BOTTLE (72737-005-02) |
| 72737-005-03 | 72737000503 | 500 CAPSULE in 1 BOTTLE (72737-005-03) |
| 72737-005-04 | 72737000504 | 1000 CAPSULE in 1 BOTTLE (72737-005-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b26fd0c6-6aab-4957-8a32-cc7adb9b5fc9
Use it
Look up 72737-005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72737-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72737-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.